002030 達安基因
按盤價 
6.170 +0.070 (+1.148%)
6.170 +0.070 (+1.148%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -4.176 | 1.037 | 58.034 | 62.275 | 80.165 |
| 總資產報酬率 ROA (%) | -3.396 | 0.812 | 43.137 | 42.476 | 47.733 |
| 投入資產回報率 ROIC (%) | -3.944 | 0.991 | 54.967 | 55.868 | 61.803 | 邊際利潤分析 |
| 銷售毛利率 (%) | 55.836 | 50.467 | 72.842 | 74.765 | 70.152 |
| 營業利潤率 (%) | -218.502 | 10.299 | 52.542 | 53.826 | 55.045 |
| 息稅前利潤/營業總收入 (%) | -226.999 | 3.285 | 51.534 | 53.355 | 54.885 |
| 淨利潤/營業總收入 (%) | -182.111 | 6.074 | 45.056 | 47.212 | 45.871 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 2.222 | 41.799 | 108.478 | 98.636 | 90.534 |
| 價值變動淨收益/利潤總額(%) | 89.311 | 360.629 | 5.594 | 3.285 | 15.033 |
| 營業外收支淨額/利潤總額(%) | 0.175 | -7.122 | -0.163 | -0.129 | -1.282 | 償債能力分析 |
| 流動比率 (X) | 3.738 | 3.085 | 2.954 | 2.374 | 2.096 |
| 速動比率 (X) | 3.567 | 2.946 | 2.829 | 2.178 | 1.943 |
| 資產負債率 (%) | 15.213 | 16.889 | 21.286 | 25.894 | 0.326 |
| 帶息債務/全部投入資本 (%) | 4.306 | 4.150 | 2.072 | 5.893 | 11.780 |
| 股東權益/帶息債務 (%) | 2,194.410 | 2,273.624 | 4,656.178 | 1,563.747 | 728.301 |
| 股東權益/負債合計 (%) | 539.639 | 477.214 | 359.775 | 274.665 | 195.327 |
| 利息保障倍數 (X) | 27.982 | -0.519 | -55.909 | -132.714 | 102.343 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 891.851 | 933.398 | 94.518 | 88.190 | 74.352 |
| 存貨周轉天數 (天) | 252.188 | 187.444 | 47.499 | 75.332 | 56.534 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 16/08/2024 12:33 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
